HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

COCH

Envoy Medical, Inc. (NASDAQ)

Healthcare — Medical Devices

Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

None 1 analysts
$0.69
+$0.01 (+1.82%)
Target: $2.50 (262.3%)
Sign in to add COCH to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$60.85M
P/E Ratio (TTM)-
Forward P/E-2.63
EPS (TTM)$-1.02
Dividend Yield-
Profit Margin-
Revenue Growth-15.20%
ROE-
Debt/Equity8.43
Recommendation None
Analyst Target$2.50
Analysts1
Indexes NASDAQ

Technical Indicators

RSI (14)71.8
Beta1.89
SMA 20-
SMA 40-
52-Week High$1.89
52-Week Low$0.36
50-Day Avg$0.68
200-Day Avg$0.74
Avg Volume395.4K
Volume156.1K

Performance Analysis

NEUTRAL

COCH presents a mixed picture with both positive and negative indicators.

~ Trading at 21% of its 52-week range.
- RSI at 71.8 indicates overbought conditions — a pullback may be due.
- Revenue declined 15.2% year-over-year.
~ Wall Street consensus is "none" from 1 analysts.
+ Average analyst target of $2.50 implies 262.3% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:04 UTC

Back to Screener Export Report